Tech Center 4100 • Art Units: 1651 1671 1672 1699 4112
This examiner grants 54% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17230821 | Methods for the Treatment of Solid Tumor Cancers Using Illudins and Biomarkers | Final Rejection | Lantern Pharma Inc. |
| 18247863 | ENGINEERED GALACTOSE OXIDASE VARIANT ENZYMES | Non-Final OA | Codexis, Inc. |
| 18192674 | METHOD AND SYSTEM FOR DELIVERING NUCLEIC ACID | Non-Final OA | Hangzhou Songyin Biomedical Science and Technology Co., Ltd. |
| 18005537 | PLURIPOTENT STEM CELLS EFFECTIVE FOR TREATMENT OF MOTOR NEURON DISEASE (MND) | Final Rejection | LIFE SCIENCE INSTITUTE, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy